Registration Dossier

Identification

Display Name:
octasodium 4,4'-(ethane-1,2-diylbis{imino[6-(4-sulfonatophenoxy)-1,3,5-triazine-4,2-diyl]imino})bis[6-({3-methyl-2,7 -dioxo-1-[(3-sulfonatophenyl)carbonyl]-2,7-dihydro-3H-naphtho[1,2,3-de]quinolin-6-yl}amino)benzene-1,3-disulfonate]
EC Name:
-
IUPAC Name:
octasodium 4,4'-(ethane-1,2-diylbis{imino[6-(4-sulfonatophenoxy)-1,3,5-triazine-4,2-diyl]imino})bis[6-({3-methyl-2,7 -dioxo-1-[(3-sulfonatophenyl)carbonyl]-2,7-dihydro-3H-naphtho[1,2,3-de]quinolin-6-yl}amino)benzene-1,3-disulfonate]

Type of substance

Composition:
mono-constituent substance
Origin:
organic

Total tonnage band

Total range:
0 - 10 tonnes per annum

REACH

Registered as:
FULL
Submitted:
Individual Submission

Publication dates

First published:
27-Apr-2012
Last modified:
20-Mar-2020

Chemical safety assessment

Performed for this substance:
NO

Compositions open all close all

Type:
legal entity composition of the substance
State Form:
solid: bulk


Registrants / Suppliers Details open all close all

Registrant / Supplier Registered Ceased manufacture
Covance Clinical Development SA 024 Parque Empresarial Las Tablas, Edificio 1 Calle Federico Mompou, 5 - 5 Planta 28050 Madrid Spain 2007 2020

Administrative data open all close all

Contact Persons responsible for the SDS